Cargando…
Different COVID-19 treatments’ impact on hospital length of stay
IMPORTANCE: COVID-19 has adversely affected global healthcare infrastructure since 2019. Currently, there are no large-scale published reports on the efficacy of combination therapy of dexamethasone, remdesivir, and tocilizumab on COVID-19 patients. OBJECTIVES: Is the combination therapy of dexameth...
Autores principales: | Iwamoto, Satori, Muhar, Bahaar Kaur, Chen, Hao, Chu, Harrison, Johnstone, Mason, Sidhu, Ashwin, Chu, Hillary, Fischer, Joseph, Chu, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316632/ https://www.ncbi.nlm.nih.gov/pubmed/37400927 http://dx.doi.org/10.1186/s40001-023-01201-8 |
Ejemplares similares
-
Isolated Hypoglossal Nerve Palsy Secondary to Oligosecretory Multiple Myeloma
por: Muhar, Bahaar K, et al.
Publicado: (2023) -
The increasing impact of length of stay “outliers” on length of stay at an urban academic hospital
por: Hughes, Andrew H., et al.
Publicado: (2021) -
Impact of Length of Stay on Readmission in Hospitalized Patients
por: Rachoin, Jean-Sebastien, et al.
Publicado: (2020) -
Appendectomy Hospital Stay: No Difference in Obese Adult or Pediatric Patient Length of Stay Compared to Nonobese Patients
por: Lorio, Eric, et al.
Publicado: (2021) -
Obesity and Mortality, Length of Stay and Hospital Cost among Patients with Sepsis: A Nationwide Inpatient Retrospective Cohort Study
por: Nguyen, Anh Tuan, et al.
Publicado: (2016)